Literature DB >> 10517757

Human angiotensin I-converting enzyme gene and endurance performance.

S Myerson1, H Hemingway, R Budget, J Martin, S Humphries, H Montgomery.   

Abstract

Human physical performance is strongly influenced by genetic factors. A variation in the structure of the human angiotensin I-converting enzyme (ACE) gene has been reported in which the insertion (I) variant is associated with lower ACE levels than the deletion (D) gene. We have previously reported that the I variant was associated with improved endurance performance in high-altitude mountaineers and British Army recruits. We now examine this genotype distribution in 91 British Olympic-standard runners (79 Caucasians). DNA was extracted from the buccal cells contained in 10 ml of saline mouthwash donated by the subjects, and the I and D variants of the ACE gene were identified by PCR amplification of the polymorphic region. There was an increasing frequency of the I allele with distance run [0.35, 0.53, and 0.62 for </=200 m (n = 20), 400-3,000 m (n = 37), and >/=5,000 m (n = 34), respectively; P = 0.009 for linear trend]. Among 404 Olympic-standard athletes from 19 other mixed sporting disciplines (in which endurance performance was not necessarily a key factor), the I allele did not differ significantly from that found in control subjects: 0.50 vs. 0.49 (P = 0.526). These results support a positive association of the I allele with elite endurance performance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517757     DOI: 10.1152/jappl.1999.87.4.1313

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  94 in total

Review 1.  Movement systems as dynamical systems: the functional role of variability and its implications for sports medicine.

Authors:  Keith Davids; Paul Glazier; Duarte Araújo; Roger Bartlett
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  A framework for understanding the training process leading to elite performance.

Authors:  David J Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction.

Authors:  Christy S Carter; Leanne Groban
Journal:  Aging health       Date:  2008-02-01

4.  Linking genes with exercise: where is the cut-off?

Authors:  Martin Flueck; David Vaughan; Håkan Westerblad
Journal:  Eur J Appl Physiol       Date:  2010-10-13       Impact factor: 3.078

5.  Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.

Authors:  Thomas W Buford; Todd M Manini; Fang-Chi Hsu; Matteo Cesari; Stephen D Anton; Susan Nayfield; Randall S Stafford; Timothy S Church; Marco Pahor; Christy S Carter
Journal:  J Am Geriatr Soc       Date:  2012-06-21       Impact factor: 5.562

6.  Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.

Authors:  Davide Seripa; Giulia Paroni; Maria G Matera; Carolina Gravina; Carlo Scarcelli; Michele Corritore; Luigi P D'Ambrosio; Maria Urbano; Grazia D'Onofrio; Massimiliano Copetti; Patrick G Kehoe; Francesco Panza; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-11-13

Review 7.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

8.  Y chromosome haplogroups of elite Ethiopian endurance runners.

Authors:  Colin N Moran; Robert A Scott; Susan M Adams; Samantha J Warrington; Mark A Jobling; Richard H Wilson; William H Goodwin; Evelina Georgiades; Bezabhe Wolde; Yannis P Pitsiladis
Journal:  Hum Genet       Date:  2004-10-20       Impact factor: 4.132

Review 9.  Association of genetic factors with selected measures of physical performance.

Authors:  William R Thompson; Stuart A Binder-Macleod
Journal:  Phys Ther       Date:  2006-04

10.  Performance at altitude and angiotensin I-converting enzyme genotype.

Authors:  G Tsianos; K I Eleftheriou; E Hawe; L Woolrich; M Watt; I Watt; A Peacock; H Montgomery; S Grant
Journal:  Eur J Appl Physiol       Date:  2004-12-01       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.